Objective: To assess the influence of health risk change on changes in health care costs. Methods: Multivariate regression models examined change in health care costs concurrent with and following completion of two health assessments (HAs) approximately 1 year apart. Final models examined changes in costs for individuals with and without chronic conditions. Results: After controlling for chronic condition status, health risk changes between the first and second HA were associated with health care cost changes in the year following the second HA. Those with chronic conditions experienced reductions of $129 for each risk reduced and increases of $210 for each risk added. Conclusions: Changes in health care costs were preceded by changes in health risk status, supporting the use of HA and biometric screening measures as leading indicators of the cost impact of health management programs.
integrating health assessment (HA) and wellness participation incentives into their health plan design, this provision has encouraged more employers to tie financial rewards to whether employees are within healthy ranges of biometric measures such as blood pressure, cholesterol, and body mass index (BMI) and whether they practice healthy behaviors such as not using tobacco. Use of an HA as part of a comprehensive population health management program is expected to increase as a result of the legislation, which may enable the HA to be used more strategically for program evaluation and program planning purposes.
The emergence of HA and screening as core health management tools is largely because of their ability to predict health care costs and engage individuals in appropriate risk management efforts. 4 High rates of HA and screening participation driven by incentives and best-practice strategies 5 are also greatly increasing the efficacy of HA and screening as evaluation tools to monitor changes in population health risk as programs are implemented.
HA and screening data also have the potential to be used by program evaluators to estimate the cost impact and return on investment of health management programs. Accurate estimates of financial outcomes using HA and screening data could preclude the need for expensive and complex health care claims analyses, as well as being a viable alternative when claims-based analyses are not feasible. Furthermore, HA data allow practitioners to intervene earlier because elevated health risks often precede health care cost increases. Although health risks have been directly associated with higher health care costs, 6, 7 there is limited research about the impact of changes in health risks on changes in health care costs. Gaining a better understanding of the magnitude and timing of changes in costs associated with changes in health risks is the purpose of this research.
LITERATURE REVIEW
Numerous studies have demonstrated the association between health risks and health care costs. [6] [7] [8] [9] [10] The most frequently cited studies found that the highest individual-level costs were associated with stress and depression risks, 7 whereas the highest populationlevel costs (accounting for risk prevalence as well as individual costs of risks) were associated with stress and obesity. 6 Other studies have reported a direct linear relationship between number of health risks and health care costs. 8, 10, 11 In addition, more specifically focused studies have found a direct relationship between units of a given health risk measure (eg, BMI) and health care costs. [12] [13] [14] [15] [16] [17] These research studies often are used to support the business case for investment in health risk reduction programs, based on the assumption that reducing these risks will yield a concomitant reduction in health care costs. Support for this assumption has grown over the past 10 years, [18] [19] [20] [21] [22] [23] [24] [25] but more research is needed for a variety of reasons. Five of the eight identified studies that addressed the impact of risk changes on health care costs included data from only one organization, 18, 20, 21, 23, 25 which limits the external validity of the findings. Although these published studies represent a mix of employer types (ie, public and private organizations and education, government, manufacturing, and health care industries), more multiemployer studies are needed to further establish the ecological validity of risk-cost relationships. There are also numerous inconsistencies in methods across studies, including which health risks were examined, how change in health risk status was defined, treatment of claims data in the analyses, and statistical procedures used in the analyses. This methodological variation makes it challenging to compare results from one study with those from another. Several of these past studies did not yield statistically significant findings even though the cost trends were consistently in the hypothesized direction, which may have been due to small sample sizes. Only three of the eight identified studies had samples of 3000 or more individuals, 18, 21, 25 which seriously limits reliable measurement in highly skewed health care claims data sets. In addition to these limitations, one study 21 did not have direct access to health care claims data and, alternatively, estimated costs by assigning average unit costs to measured utilization of services. Although the results of these studies generally support a direct relationship between health risk changes and health care cost changes, these limitations make it difficult for program evaluation practitioners to use the results of these studies to quantify the cost impact of changes in health risks by participants in their programs.
A final important limitation in the published research about the association between health risk changes and health care cost changes is the uncertainty of the temporal relationship between the independent risk variables and the dependent cost variables. Two early studies blended 3 years of claims data for each comparative time period, 20, 23 with the HA typically selected from the first or second and the fourth year, respectively, of a 6-year study period. Although this treatment yielded one or more years of health care costs following each HA period, the temporal relationship between risk and cost measures was difficult to determine because the researchers aggregated costs in multiple ways from the years before, during, and after the HA administration year. A more recent study 25 tracked annual costs for each of three consecutive years but, because the cost data were for the same years as the HA and screening administration, there was no ability to observe health care cost patterns for a period of time following a change in health risk status. A recent longitudinal cohort study analyzed over 4 years of follow-up claims experience after the second HA was administered, 18 but this study differed from previous research by focusing on change in specific health risks rather than change in number of health risks. The strength of this study was that it measured how changes in specific health risks were associated with future health care cost changes. Unfortunately, the overall sample size and very mature program, which was focused on low-risk maintenance, resulted in too few individuals making changes in most health risks to have enough statistical power to reliably detect associated changes in costs.
This study aimed to address these limitations in past research by integrating data from six large and diverse employers representing the finance, manufacturing, health care, energy, and education industries. Nearly 23,000 individuals were included in the analysis, which combined standardized HA data from a single provider of health management services with health care (ie, medical and pharmacy) claims data from a single data warehouse provider. This much larger sample compares with a median sample size of slightly more than 2000 in past research. In addition, the study summed at-risk status across 14 modifiable health risk factors for each individual to create a single health risk measure (ie, number of health risks) as the independent variable. Finally, this study clearly defined the temporal relationship between HA completion and occurrence of health care costs. Together, these design features enabled this study to effectively address four important research questions: (1) Are changes in number of health risks associated with changes in health care costs? (2) What is the timing of cost changes vis-à-vis changes in health risks? (3) Does the change in costs related to health risk change differ between those with versus without chronic conditions? (4) Are cost reductions associated with reducing the number of health risks greater than or less than cost increases associated with increasing the number of health risks over time?
METHODS

Data Sources
The data for this study were from six large employers representing diverse industry sectors, including manufacturing, health care, financial, education, and energy. Self-reported HA data were collected, with completion dates ranging from October 2004 through December 2007. All employers in the study used an HA from one health management program provider, and the HA was validated in previously published studies. 6, 7, 26 Employee health plan enrollment and transaction-level medical and pharmaceutical claims data were collected from January 2004 through March 2009. Annual calendar-year health care costs were based on allowed medical and pharmaceutical costs (plan payments plus employee out-of-pocket expenses) and incurred claims date (claims incurred during the calendar year and paid through the 3 months after the calendar year). All costs were inflation adjusted to 2006 dollars using the medical Consumer Price Index from the Bureau of Labor Statistics because 2006 was the most recent common year across all cases included in the sample. Occurrences of negative total claims values for a year (as a result of claims adjustments by the plan) were set to zero.
Sample
The primary analysis included employees and dependents To preserve this timing, HAs completed from March through August in any given year were excluded from the analysis. Because most HAs were completed in October or November in any given year, this exclusion criterion resulted in a clear temporal relationship between health risk measurement and health care claims occurrence while excluding only 5% (n = 2754) of the sample that met other criteria of the study. A graphical representation of study timeframes is provided in Fig. 1 .
A total of 21,380 unique employees and dependents met the requirements of two consecutive years of HA participation and three temporally related consecutive years of health care claims eligibility during the study period, as shown in Fig. 1 (ie, baseline claims year preceding the baseline HA and third claims year following the second HA). In total, 9% of respondents (n = 1992) in the final sample were dependents. Table 1 presents the total population enrolled in health plan coverage (ie, claims data), the number of HA participants, and the subset of individuals in the final sample included in the analysis. HA, health assessment. *Dependents for employer B were not eligible to complete the health assessment. †Baseline claims and baseline HA are the same year, and third claims year follows second HA.
examined health risks and health care claims to compare group differences by year. A series of multivariate least-squares regression models were run to estimate the predicted change in allowed health care costs (ie, the dependent variable) associated with changes in number of health risks (ie, the independent variable). † Regression model estimates were adjusted for differences in age, sex, and average claims costs aggregated across the 3-year claims period. In addition, employer dummy variables were included to control for unique characteristics of the six employers that could potentially explain the variation in cost change.
The first set of models used a concurrent approach to examine health care cost patterns during the same calendar year as completion of an HA. The second set of models used a more prospective approach to examine how health care costs changed in the period following completion of the HA. A final set of models was used to examine differences for those with and without chronic conditions, in which chronic condition status was based on a list of International Classification of Diseases, 9th Revision, codes and definitions †To support selection of a least-squares model, we reviewed the residual plot as part of our model evaluation. The normal probability plot did not indicate substantial deviation from normality, largely as a result of differences in the tails of the distribution. To examine the robustness of our model estimates, we performed a series of sensitivity tests, re-estimating the models by excluding various high cost claimants from the sample. Although the magnitude of the estimates decreased for greater exclusions between 25% and 30%, results improved normality and revealed consistent signs and significance for the estimated risk-change parameters. The robustness of the estimates from the sensitivity analysis improved our confidence that ordinary least squares models provide an acceptable fit for this data. Model estimates from the sensitivity analysis are available upon request.
established by the Healthcare Cost and Utilization Project/Agency for Healthcare Research and Quality. 27 The chronic condition models relied on baseline claims data to stratify the sample into two groups (those with and those without an identified chronic condition) and controlled for chronic condition(s) that emerged in subsequent claims periods in the prospective models.
Health Risk Definitions
This study defined 14 health risks (Table 2 ) on the basis of responses to HA questions and available biometric screening measures (ie, weight, blood pressure, total cholesterol, and glucose). The focus of the study was to determine the relationship between changes in health risks and changes in health care costs. To distinguish between modifiable and nonmodifiable health risks, we excluded factors that represented health outcomes rather than modifiable risks (eg, selfreported health status, absence from work, medical problems). 4 A portion of the sample included biometric measures collected during worksite health screenings, but most individuals in the sample did not have these data. Of the HA cases included in the study, only about 19% had cholesterol values populated, 10% had blood pressure values, and 17% had glucose values. For participants with missing biometric values, risk status was determined on the basis of whether the respondent indicated in the HA that their doctor had told them they had any of the following chronic conditions: "high blood pressure," "high/unhealthy cholesterol," and "diabetes type 1 or type 2." Although taking full advantage of available data, this approach may have underrepresented risk prevalence for blood pressure, cholesterol, and glucose. 38 Score 7 or more on a weighted index including the following factors: current back pain (7 points); work requires regular lifting (5 points); high physical activity risk level (4 points); lack of flexibility exercises (3 points); lack of strength exercises (2 points); high stress risk level (1 point); high depression risk level (1 point); overweight (1 point); smoking (1 point). Blood pressure (M + H) 39, 40 Systolic blood pressure >139 or diastolic blood pressure >89 or self-report as previously diagnosed with high blood pressure. Cholesterol* † (H) 41, 42 If had CHD or CHD risk equivalent: total cholesterol measure (mg/dL) ≥ 200, HDL < 40, or LDL ≥ 100. If 2+ CHD risk factors: total cholesterol measure (mg/dL) ≥ 200, HDL < 40, or LDL ≥ 130. If 0-1 CHD risk factors: total cholesterol measure (mg/dL) ≥ 240, or LDL ≥ 190 or self-report as previously diagnosed. Depression (M + H) 43 Some indication of current depression (ie, over past 2 weeks) but did not report chronic depression (ie, feeling depressed most of the time). Driving (M + H) 44 Sometimes wore seatbelt or drove under influence of alcohol or rode with a driver who was under the influence of alcohol. Glucose/diabetic (H) 45, 46 Diabetic or glucose ≥100 with fasting and/or doctor diagnosed with diabetes. Nutrition (H) 47 Regular eating habits included few of the characteristics of a healthy diet. Eats very few healthy foods. May consume too many servings of foods high in trans fats or saturated fats. Physical activity (H) 48 Did not exercise vigorously and participated in less than 3 days per week of moderate-intensity physical activity. Preventive examinations (M + H) 49, 50 Lack of one or more screenings and immunizations identified as "A or B Recommendations" by the US Preventive Services Task Force (as of time of HA administration) for the general population according age and sex, for those with or without personal or family history of related health problems. Self-care (M + H) ‡ Indicated only moderate or no ability to treat common ailments at home and did not use reference information at home to decide when to call or visit a health professional. Stress (H) 51 Almost always felt troubled by stress and self-reported did not handle stress well. Tobacco (M + H) 52 Indicated some tobacco use including use of smokeless tobacco, a pipe, and/or cigarettes. Weight (H) 53 BMI ≥30 kg/m 2 ; or BMI ≥25 kg/m 2 and <30 kg/m 2 and waist circumference >40 in for men and >35 in for women BMI, body mass index; H, high risk; HA, health assessment; HDL, high-density lipoprotein; LDL, low-density lipoprotein; M, moderate risk. *Risk equivalents: diabetes; CHD risk factors conferring 10-year risk >20%. †CHD risk factors: cigarette smoking; hypertension (blood pressure >140/90 mm Hg or on antihypertensive medication); HDL >40 mg/dL (HDL >60 mg/dL counts as a "negative" risk factor and removes one risk factor from the total count); family history of premature CHD (males aged <55 years and females aged <65 years); age (men ≥ 45 years; women ≥ 55 years).
‡On the basis of consultation with Park Nicollet Medical Foundation (1993) and Harriet Imrey, PhD (2002).
For each of the 14 health risk areas, individuals were originally classified in the HA into three risk levels (low risk, moderate risk, and high risk). These categories were further grouped to form dichotomous health risk variables, with moderate-risk and high-risk levels combined into an "at-risk" status for each of the 14 health risks ( Table 2 ). These dichotomous health risk variables were summed to yield the total number of at-risk health areas. Change in number of health risks from the first to the second HA served as the primary independent variable in the regression models. To enable descriptive comparisons with previously published research, these dichotomous at-risk measures were also grouped into categories of zero to two, three to four, and five or more risks.
RESULTS
A total of 21,380 unique employees and dependents met all criteria for inclusion in the study sample (Table 3) . Each completed HAs in two consecutive years and had three consecutive years of health care claims data, with the majority of the first year (at least 8 months) of claims data preceding the first HA and the last year of claims data following the second HA. Those in the study sample averaged 44 years of age at the time they completed the baseline HA and were evenly split between men and women. More than half of these individuals (53%) had at least one chronic condition diagnosis during the 3-year study period. Average annual health care costs over the entire period was $3428 per member per year, with 17% of individuals surpassing $10,000 and 1% eclipsing $50,000 in at least 1 of the 3 years.
The percentage of individuals with at-risk status was highest for the preventive examination, back pain, and weight risks, whereas glucose, self-care, and alcohol risks had the fewest at-risk individuals (Table 4) . Nearly 30% of individuals in the study sample were obese (ie, BMI ≥ 30), which was slightly below the national average. 28 The net change in at-risk status during the study period (from baseline to year-2 HA) ranged from a 2% increase in risk prevalence for blood pressure to a 5% decrease in risk prevalence for preventive examinations, with an average 1.5% decrease in risk prevalence across the 14 health risk areas. The average number of health risks on the baseline HA was 2.90 (standard deviation [SD], 2.02), and this number decreased to 2.70 (SD = 1.95) in the following year's HA. For individuals who increased their total number of health risks, the average change was +1.65 (SD = 0.96); for individuals who decreased their total number of health risks, the average change was −1.77 (SD = 1.03). To support comparisons with previously published studies about risk migration, three summary risk levels or "risk groups" were created from the 14 health risks: a "low-risk" group included those with two or fewer health risks (ie, number of at-risk areas), a "moderate-risk" group included those with three or four health risks, and a "high-risk" group including those with five or more health risks. About half the study sample was in the low-risk group (ie, 0 to 2 at-risk areas) and nearly a third was in the moderate-risk group (3 or 4 at-risk areas) each year. About one in five individuals in the study sample was in the high-risk group (5 or more at-risk areas) each year. Nearly half of individuals (48%) in the high-risk group moved to a lower-risk group between the baseline and year-2 HA, and 39% of the moderate-risk group moved to the low-risk group in year 2. That was offset by an increase in risk among about one in five of those in both the low-risk (22%) and moderate-risk (17%) groups between the baseline and year-2 HA. Table 5 shows 3-year average costs and the annual change in costs between year 1 and year 2 and between year 2 and year 3 for the eight combinations of risk groups, based on year-1 versus year-2 risk assessments. These results represent actual costs not controlled for confounders. Average costs were consistently higher for those moving to higher-risk groups and for those remaining in the highrisk group. Likewise, average costs were lower for those moving to lower-risk groups and for those in the low-risk group in both years. Those in the low-risk group in both year 1 and year 2 had the lowest average annual cost of $2789, whereas those in the high-risk group in both years had the highest average cost of $4876-nearly 75% higher than those maintaining a low-risk status.
The largest increases in costs occurred among those moving to higher-risk groups, and these cost increases were larger between year 2 and year 3 than between the first two years. For example, those changing from low-risk to high-risk status had an average annual increase in costs of $728 between year 2 and year 3 compared with an increase of $206 between year 1 and year 2. A similar result occurred for individuals who started in the low-risk group and moved to moderate-risk status, although the average annual increase in costs in the latter period of $421 was smaller than for those moving from low-risk to high-risk status. Conversely, individuals reducing their risk status from high to low experienced only an $11 increase in costs between year 2 and year 3 compared with $284 from year 1 to year 2. Likewise, those shifting from high-risk to moderate-risk status had a reduction in costs of $55 in the latter period compared with a $645 increase in the earlier period.
The unadjusted descriptive analysis provided relatively weak evidence about the relationship between risk change and the change in costs during the initial concurrent period, that is, between year 1 and year 2. However, there was a consistent and direct relationship between risk change and cost change in the prospective period, that is, between year 2 and year 3. These patterns suggest that the impact of risk change on health care costs may take a year or more to emerge. Descriptive results for cost changes associated with changes in number of health risks are provided in Fig. 2 .
The next step in the analysis was to apply regression procedures to these aforementioned relationships. In this step, the independent variable was the specific change in the number of risks rather than the shift among the summary risk groups (eg, low-risk to low-risk group, low-risk to moderate-risk group). Table 6 reports the regression model estimates, which linked the change in risks to the change in costs between year 1 and year 2. Alternative model specifications were provided to test the robustness of the estimates by adding various control variables assumed to be important covariates with changes in health care costs, including average annual costs and chronic condition status. As in the descriptive analysis, there was no significant change in health care costs between year 1 and year 2 for those adding health risks over the same period. This result was consistent across all model specifications. However, those reducing health risks between year 1 and year 2 were linked to a decline in average annual health care costs of about $97 per each risk reduced. This suggests that there was an asymmetric relationship between risk change and cost change. That is, a reduction in health risks was associated with a reduction in health care costs the same year, whereas an increase in health risks had no direct relationship with costs in the concurrent period.
When the multivariate analysis was extended to examine cost changes between year 2 and year 3, a consistent pattern emerged, with changes in prospective health care costs moving in the same direction as changes in health risks (Table 6 ). Health care costs declined a statistically significant $105 per risk reduced between year 2 and year 3. This estimate was similar in magnitude to that between year 1 and year 2, extending the savings associated with a reduction in risks over multiple years. Conversely, although the impact of an increase in risks on costs was not statistically significant between year 1 and year 2, increasing risk was associated with a health care cost increase of $145 between year 2 and year 3 for each health risk added the previous year.
An important observation from the multivariate analysis was that each health risk added had a larger impact on costs between year 2 and year 3 than each risk reduced. Specifically, costs increased by $145 for each risk added compared with a $105 decline in costs for each risk reduced, with this difference being statistically significant (F = 11.80; P = 0.0006).
An important covariate in each of the multivariate models for both the concurrent and prospective periods was the presence of a chronic condition in a given year. Accordingly, Table 7 shows separate estimates in the prospective period for those with and without a chronic condition in year 1. By stratifying respondents in this way, the analysis isolated the impact that changes in health risks had on health care costs for those who were managing a chronic health condition compared with those who were not. Some individuals subsequently developed a chronic condition, which was controlled for in the alternative model specifications.
The regression estimates revealed a consistent pattern between risk and cost change (Table 7) . For both chronic and nonchronic models, an increase in risks had a more significant impact on costs the following year than a reduction in risks. However, the estimates were only statistically significant for those with a chronic condition in year 1. Regardless of whether health risks were added or reduced, the relationship between risk change and cost change among those without a chronic condition was not statistically significant in this smaller subsample, although the nonsignificant increase in costs the following year for each risk added was $101. For those in the subsample with a chronic condition, however, the impact of increasing risk on the following year's health care costs was a statistically significant and larger $210 for each health risk added. Similarly, average health care costs were estimated to drop a nonsignificant $25 the following year for each risk reduced in the subsample with no chronic conditions, but costs dropped by $129 for each risk reduced among those with chronic conditions, although this sizable cost reduction estimate was only marginally significant (P = 0.079). immediate, the association between increased risk and increased costs was larger by the year after the risk change. Not surprisingly, cost changes associated with both decreases and increases in health risks were much larger among individuals with chronic conditions. This research addresses key limitations of past research by assembling the largest sample ever used for this type of cost impact analysis and including individuals from multiple diverse organizations, which increases the reliability and external validity of the reported associations between health risk changes and health care cost changes. This study is also the first to explore the specific timing of cost changes vis-à-vis increases or decreases in health risks, which better supports using these data in developing estimates of the financial impact of improvements in individual and population health risks.
Although providing greater precision regarding the timing of financial impact, this research included cost data only for the year of and 1 year after risk change. Because epidemiologic evidence has shown that the health benefits of some health risk changes unfold over longer time periods, 29 using the cost parameters from this study to estimate longer-term changes may underestimate financial impact. Future research should extend the follow-up period to more fully and precisely capture the longer-term financial impact of risk change. In addition, this study did not control for the changes in health risks between years 2 and 3. For example, those reducing costs between years 2 and 3 may have taken additional steps in those years to reduce health risks. This additional risk reduction could have driven cost lower. We assume that the risk change between years 1 and 2 was the source of the cost reduction, but it may just reflect a snapshot of the process of change a member is taking. For example, the pattern of relatively high cost increases during the year risks decreased followed by relatively low cost increases the year after suggests that those starting at higher risk may have reduced their risks in response to baseline-year medical problems that subsequently were resolved through some combination of medical intervention and lifestyle risk reductions. Future research should control for multiple years of risk change that would allow for greater precision in understanding cost change and timing. Those considering the use of these study results to estimate financial impact or return on investment should recognize that associations based on voluntary change may not represent the causal impact of changes in health risks on health care costs due to the likelihood of baseline health differences between changers and nonchangers. For example, symptoms of emergent chronic disease or predisease may motivate many individuals to decrease health risks while also leading to incremental treatment costs. This may be one reason previous studies found that the health care costs associated with past smoking are higher than costs associated with current smoking. 7 Likewise, individuals who were motivated to get preventive health examinations as a result of their HA results may have increased health care costs in the short term. Similarly, individuals in good health may be less concerned about increases in their health risks and be more likely to forego medical visits than individuals in deteriorating health who feel more compelled to visit the doctor. Such health-associated motivational differences would lead to underestimating the financial impact of both risk reduction and risk increases. Future research with large enough data sets and measures of relevant health and motivational factors 30 may be able to evaluate or control for the potential effects of such differences on health care costs.
One of the challenges in comparing the results of this research with past work is the lack of standard approaches to defining the nature and extent of health risks, as well as measurement variations in the underlying HA tools. Although this study combined moderaterisk and high-risk levels and compared at-risk with low-risk levels in the analysis, other studies have contrasted high-risk with lower-risk levels. 6, 7 This study provides descriptive results to allow for some comparisons with these previous studies, but the regression results from this study are not comparable with studies that grouped risk levels into categories. In addition, this study included only health risks directly modifiable through behavior change, whereas others have included health care cost predictors such as health status, life satisfaction, and absence from work as "health risks" in their models. 4 Because this lack of consistency in definitions of health risk makes direct cross-study comparisons difficult or impossible, we encourage efforts to develop standards for risk definitions.
Similar to several of the studies addressing the effects of risk change on cost changes, 19, 20, 25 we defined change on the basis of number of health risks. Other studies have focused on cost changes associated with change in specific health risks. 18, [21] [22] [23] The definition of change we used enabled us to increase variation in the independent variable--health risk change--to overcome the limitation that only small numbers of individuals in the study population increased or decreased their risk level for most of the individual health risks (Table  4) . Although our approach has the advantage of providing a useful population-level model and greater statistical power in detecting the global effects of risk change on costs, it does not provide a full understanding of the effects of changes in specific health risks. The small number of statistically significant effects reported by Carls et al 18 in their study using a sample of about 10,000 individuals illustrates the need for very large data sets to better assess the effects of change in specific health risks and subsequent change in related claims costs.
A notable limitation of this research is that most individuals in the study sample were missing biometric screening values (19% had cholesterol, 10% had blood pressure, and 17% had glucose). To overcome this limitation, we relied on self-reported diagnosis of a related chronic condition such as high cholesterol, high blood pressure, or diabetes as a proxy measure for an at-risk biometric value. In effect, this methodological decision resulted in a variable for these factors that defined at-risk status as either having an elevated biometric measure or reporting a diagnosis, based on past elevations in this measure. We recognize that this leads to underrepresentation of risk in these areas because many individuals missing data may have actually had elevated values, an undiagnosed chronic condition, or a diagnosed condition that they were unaware they had. Another limitation of this study is that most of the health risk data were based on self-reported responses about an HA. Although the HA used in this research is among the most extensively validated and researched such instrument, 6, 7, 16, 26 reliance on self-reported health risk data introduces some inherent measurement error into the analysis and interpretation of results. Even so, these study results serve as another form of validation for such self-reported instruments, based on the association between self-reported health data and health care claims data.
Although our results begin to credibly quantify the economic return that may accrue from prevention, we urge continued investigation into the health care utilization patterns of higher-risk versus lower-risk individuals. For example, this study showed that maintaining lower-risk levels kept health care costs lower for those both with and without chronic health conditions. What remains to be explored in longer-term studies is whether there is a point of diminishing return wherein less current investment in health care by those with chronic conditions may increase their future expenditures. Conversely, for those with chronic conditions, increased health risks had a larger cost consequence than increased risks for those without a chronic condition. If this is a snowball effect, the economic case for secondary prevention (delaying further disease) may outweigh the case for primary prevention (delaying the onset of disease) in some populations.
These findings can play a critical role in advancing a 35-yearold concept that has tremendous face validity but has had surprisingly little scientific support or policy inertia. The report by Lalonde 31 about the health of Canadians, issued in 1974, was arguably the first of numerous national policy positions outlining the economic potential of disease prevention. Lalonde 31 argued that disease prevention, including efforts at improving lifestyles and environments, was needed so that "the cost of present services will go down, or at least the rate of increase will diminish." Soon after, Julias Richmond, the US Surgeon General, issued "Healthy People," a national policy initiative based on the premise that "national efforts designed to prevent disease and promote health" were needed to curb the nation's health expenditures. 32 Thirty years later, the surgeon general's 2020 report still calls for more investment in prevention, albeit within a broader context, noting that "the strongest predictors of health and well-being fall outside the health care setting. Our housing, transportation, education, workplaces and environments are major elements that impact the physical and mental health of Americans." 33 After three decades of conceptual arguments on behalf of the financial merits of prevention, only 3% of the more than two trillion dollars spent annually on health care is designated toward keeping healthy people healthy. 34 We believe one impediment to deeper investment in keeping healthy people healthy has been the dearth of quantifiable savings. 1 The uncomfortable paradox for prevention advocates (ie, the financial yield from something that does not occur will always be unknown and unknowable) underscores the importance of the approach used in this study. By focusing on health risks that are modifiable through health behavior changes in a large, representative sample and examining the cost impact of both positive and negative risk migration, this study provides a compelling illustration of the economic advantages of disease prevention compared with risk reduction.
CONCLUSIONS
This study provides a substantial contribution to the sparse literature concerning the positive financial impact of keeping healthy people healthy. Using a large sample and well-established risk definitions, we show that claims cost increases associated with increased risk were markedly greater than cost decreases associated with comparable decreases in risk. Furthermore, we show the magnitude of cost increases for those increasing their risks were amplified for those who moved from the lowest to the highest risk levels.
This research should help employers and other sponsors of health management programs decide upon investment strategies that will best achieve their objectives. For example, if the objective is to get the fastest and largest return from investing in the smallest number of employees, the suggested strategy would be to offer programs that engage chronically ill employees in avoiding taking on additional risk. If program sponsors tolerate a longer time frame for returns but desire greater total returns, the suggested strategy would be to offer programs that engage the healthy as well as programs that engage the ill in avoiding taking on additional risk. Finally, if program sponsors tolerate longer time frames and lower returns per person but desire to maximize total returns, the suggested strategy would be to offer programs to both the healthy and ill and programs that engage participants in both avoiding additional risk and in reducing preexisting risk.
These positive and striking findings concerning the economic savings attributable to keeping healthy people healthy support the need for additional research into the comparative effectiveness of dollars invested upstream of conditions compared with money spent in risk reduction for those with health problems. This study supports the premise that sustaining a low-risk behavior such as physical activity has health and economic benefits similar to the "compression of morbidity" concept. 35 Similarly, although it has been argued that intensive (and relatively expensive) lifestyle interventions with the potential for reversing heart disease are more cost-effective than invasive medical interventions, 36 this study suggests that interventions much further upstream could have a substantially more powerful economic impact.
